Clinical Trial

Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registry

Study acronym: MICAT
Recruiting
View on ClinicalTrials.gov →
Summary
Primary goal of the registry is to collect prospective data on patients undergoing coronary angiography in Mainz. Following amendment of the procol, this study will also include patients who received an Aborb bioresorbable scaffold for the therapy of de novo stenoses.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2014-07-01; most recent amendment 2024-10-06.
Trial Details
NCT Number NCT02180178
Lead Sponsor Johannes Gutenberg University Mainz
Conditions Coronary Artery Disease, Microvascular Dysfunction
Enrollment 1,000 participants
Start Date 2013-09
Primary Completion 2028-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2024-10-08